Life Science

Global Fragment-based Drug Discovery Market Analysis By Type, Application, Regions and Companies Forecast 2016-2027

Report Format PDF, PPT, Excel
No. of Pages 97
The latest study on Fragment-based Drug Discovery Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Fragment-based Drug Discovery Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Fragment-based Drug Discovery and is a must have data for all the companies, investors, decision makers, top level executives and readers. The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027. The major vendors covered: Astex Pharmaceuticals Alveus Pharmaceuticals Beactica Charles River Laboratories Crown Bioscience Emerald BioStructures Evotec Kinetic Discovery Proteros Fragments Sprint Bioscience Structure Based Design Sygnature Discovery Fragment-based Drug Discovery Market Analysis By Type Segment: Fragment Screening Fragment Optimization Fragment-based Drug Discovery Market Analysis By Application Segment: Biopharmaceutical Companies CROs Academic and Research Institutions Fragment-based Drug Discovery Market Analysis By Regions (Countries): The Fragment-based Drug Discovery Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions. Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions. Key Details of Regions and Countries of Fragment-based Drug Discovery Report: North America United States Canada Mexico Europe Germany France UK Italy Russia Asia-Pacific China Japan South Korea India Australia Indonesia Thailand Malaysia Philippines Vietnam Central & South America Brazil Middle East & Africa Turkey GCC Countries Egypt South Africa Key data provided: Market Size of Regions Market Share of Regions Compound Annual Growth Rate (CAGR) Historic Data From 2016-2020 Forecast Data From 2021-2027 Competitive Landscape of Fragment-based Drug Discovery Market: Fragment-based Drug Discovery market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market. Key Questions Answered in Competitive Landscape- List of Key Players Revenue By players Market share of players Product Offerings The study objectives are: To analyze and research the Fragment-based Drug Discovery Market status and future forecast. To present the key Fragment-based Drug Discovery Market analysis of companies and present revenue, market share, and recent development for key players. To split the breakdown data by regions, type, companies and applications To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. To identify significant trends, drivers, influence factors in global and regions To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Fragment-based Drug Discovery Market Size Growth Rate by Type (2016-2027) 1.4.2 Fragment Screening 1.4.3 Fragment Optimization 1.5 Market by Application 1.5.1 Global Fragment-based Drug Discovery Market Share by Application (2016-2027) 1.5.2 Biopharmaceutical Companies 1.5.3 CROs 1.5.4 Academic and Research Institutions 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Fragment-based Drug Discovery Market Size 2.2 Fragment-based Drug Discovery Growth Trends by Regions 2.2.1 Fragment-based Drug Discovery Market Size by Regions (2016-2027) 2.2.2 Fragment-based Drug Discovery Market Share by Regions (2016-2020) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Fragment-based Drug Discovery Market Size by Manufacturers 3.1.1 Global Fragment-based Drug Discovery Revenue by Manufacturers (2020) 3.1.2 Global Fragment-based Drug Discovery Revenue Market Share by Manufacturers (2020) 3.1.3 Global Fragment-based Drug Discovery Market Concentration Ratio (CR5 and HHI) 3.2 Fragment-based Drug Discovery Key Players Head office and Area Served 3.3 Key Players Fragment-based Drug Discovery Product/Solution/Service 3.4 Date of Enter into Fragment-based Drug Discovery Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Fragment-based Drug Discovery Market Size by Type (2016-2020) 4.2 Global Fragment-based Drug Discovery Market Size by Application (2016-2020) 5 United States 5.1 United States Fragment-based Drug Discovery Market Size (2016-2020) 5.2 Fragment-based Drug Discovery Key Players in United States 5.3 United States Fragment-based Drug Discovery Market Size by Type 5.4 United States Fragment-based Drug Discovery Market Size by Application 6 Europe 6.1 Europe Fragment-based Drug Discovery Market Size (2016-2020) 6.2 Fragment-based Drug Discovery Key Players in Europe 6.3 Europe Fragment-based Drug Discovery Market Size by Type 6.4 Europe Fragment-based Drug Discovery Market Size by Application 7 China 7.1 China Fragment-based Drug Discovery Market Size (2016-2020) 7.2 Fragment-based Drug Discovery Key Players in China 7.3 China Fragment-based Drug Discovery Market Size by Type 7.4 China Fragment-based Drug Discovery Market Size by Application 8 Japan 8.1 Japan Fragment-based Drug Discovery Market Size (2016-2020) 8.2 Fragment-based Drug Discovery Key Players in Japan 8.3 Japan Fragment-based Drug Discovery Market Size by Type 8.4 Japan Fragment-based Drug Discovery Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Fragment-based Drug Discovery Market Size (2016-2020) 9.2 Fragment-based Drug Discovery Key Players in Southeast Asia 9.3 Southeast Asia Fragment-based Drug Discovery Market Size by Type 9.4 Southeast Asia Fragment-based Drug Discovery Market Size by Application 10 India 10.1 India Fragment-based Drug Discovery Market Size (2016-2020) 10.2 Fragment-based Drug Discovery Key Players in India 10.3 India Fragment-based Drug Discovery Market Size by Type 10.4 India Fragment-based Drug Discovery Market Size by Application 11 Central & South America 11.1 Central & South America Fragment-based Drug Discovery Market Size (2016-2020) 11.2 Fragment-based Drug Discovery Key Players in Central & South America 11.3 Central & South America Fragment-based Drug Discovery Market Size by Type 11.4 Central & South America Fragment-based Drug Discovery Market Size by Application 12 International Players Profiles 12.1 Astex Pharmaceuticals 12.1.1 Astex Pharmaceuticals Company Details 12.1.2 Company Description and Business Overview 12.1.3 Fragment-based Drug Discovery Introduction 12.1.4 Astex Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2020) 12.1.5 Astex Pharmaceuticals Recent Development 12.2 Alveus Pharmaceuticals 12.2.1 Alveus Pharmaceuticals Company Details 12.2.2 Company Description and Business Overview 12.2.3 Fragment-based Drug Discovery Introduction 12.2.4 Alveus Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2020) 12.2.5 Alveus Pharmaceuticals Recent Development 12.3 Beactica 12.3.1 Beactica Company Details 12.3.2 Company Description and Business Overview 12.3.3 Fragment-based Drug Discovery Introduction 12.3.4 Beactica Revenue in Fragment-based Drug Discovery Business (2020) 12.3.5 Beactica Recent Development 12.4 Charles River Laboratories 12.4.1 Charles River Laboratories Company Details 12.4.2 Company Description and Business Overview 12.4.3 Fragment-based Drug Discovery Introduction 12.4.4 Charles River Laboratories Revenue in Fragment-based Drug Discovery Business (2020) 12.4.5 Charles River Laboratories Recent Development 12.5 Crown Bioscience 12.5.1 Crown Bioscience Company Details 12.5.2 Company Description and Business Overview 12.5.3 Fragment-based Drug Discovery Introduction 12.5.4 Crown Bioscience Revenue in Fragment-based Drug Discovery Business (2020) 12.5.5 Crown Bioscience Recent Development 12.6 Emerald BioStructures 12.6.1 Emerald BioStructures Company Details 12.6.2 Company Description and Business Overview 12.6.3 Fragment-based Drug Discovery Introduction 12.6.4 Emerald BioStructures Revenue in Fragment-based Drug Discovery Business (2020) 12.6.5 Emerald BioStructures Recent Development 12.7 Evotec 12.7.1 Evotec Company Details 12.7.2 Company Description and Business Overview 12.7.3 Fragment-based Drug Discovery Introduction 12.7.4 Evotec Revenue in Fragment-based Drug Discovery Business (2020) 12.7.5 Evotec Recent Development 12.8 Kinetic Discovery 12.8.1 Kinetic Discovery Company Details 12.8.2 Company Description and Business Overview 12.8.3 Fragment-based Drug Discovery Introduction 12.8.4 Kinetic Discovery Revenue in Fragment-based Drug Discovery Business (2020) 12.8.5 Kinetic Discovery Recent Development 12.9 Proteros Fragments 12.9.1 Proteros Fragments Company Details 12.9.2 Company Description and Business Overview 12.9.3 Fragment-based Drug Discovery Introduction 12.9.4 Proteros Fragments Revenue in Fragment-based Drug Discovery Business (2020) 12.9.5 Proteros Fragments Recent Development 12.10 Sprint Bioscience 12.10.1 Sprint Bioscience Company Details 12.10.2 Company Description and Business Overview 12.10.3 Fragment-based Drug Discovery Introduction 12.10.4 Sprint Bioscience Revenue in Fragment-based Drug Discovery Business (2020) 12.10.5 Sprint Bioscience Recent Development 12.11 Structure Based Design 12.12 Sygnature Discovery 13 Market Forecast 2021-2027 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2021-2027) 13.10 Market Size Forecast by Application (2021-2027) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures

List of Tables and Figures Table Fragment-based Drug Discovery Key Market Segments Table Key Players Fragment-based Drug Discovery Covered Table Global Fragment-based Drug Discovery Market Size Growth Rate by Type 2016-2027 (Million US$) Figure Global Fragment-based Drug Discovery Market Size Market Share by Type 2016-2027 Figure Fragment Screening Figures Table Key Players of Fragment Screening Figure Fragment Optimization Figures Table Key Players of Fragment Optimization Table Global Fragment-based Drug Discovery Market Size Growth by Application 2016-2027 (Million US$) Figure Biopharmaceutical Companies Case Studies Figure CROs Case Studies Figure Academic and Research Institutions Case Studies Figure Fragment-based Drug Discovery Report Years Considered Table Global Fragment-based Drug Discovery Market Size 2016-2027 (Million US$) Figure Global Fragment-based Drug Discovery Market Size and Growth Rate 2016-2027 (Million US$) Table Global Fragment-based Drug Discovery Market Size by Regions 2016-2027 (Million US$) Table Global Fragment-based Drug Discovery Market Size by Regions 2016-2020 (Million US$) Table Global Fragment-based Drug Discovery Market Share by Regions 2016-2020 Figure Global Fragment-based Drug Discovery Market Share by Regions 2016-2020 Figure Global Fragment-based Drug Discovery Market Share by Regions 2020 Table Market Top Trends Table Global Fragment-based Drug Discovery Revenue by Manufacturers (2020) (Million US$) Table Global Fragment-based Drug Discovery Market Share by Manufacturers (2020) Figure Global Fragment-based Drug Discovery Market Share by Manufacturers in 2020 Table Global Fragment-based Drug Discovery Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Fragment-based Drug Discovery Product/Solution/Service Table Date of Enter into Fragment-based Drug Discovery Market Table Mergers & Acquisitions, Expansion Plans Table Global Fragment-based Drug Discovery Market Size by Type (2016-2020) (Million US$) Table Global Fragment-based Drug Discovery Market Size Share by Type (2016-2020) Figure Global Fragment-based Drug Discovery Market Size Market Share by Type (2016-2020) Table Global Fragment-based Drug Discovery Market Size by Application (2016-2020) (Million US$) Table Global Fragment-based Drug Discovery Market Size Share by Application (2016-2020) Figure Global Fragment-based Drug Discovery Market Size Market Share by Application (2016-2020) Figure Global Fragment-based Drug Discovery Revenue Market Share by Application in 2020 Figure United States Fragment-based Drug Discovery Market Size 2016-2020 (Million US$) Table United States Key Players Fragment-based Drug Discovery Revenue (2020) (Million US$) Table United States Key Players Fragment-based Drug Discovery Market Share (2020) Table United States Fragment-based Drug Discovery Market Size by Type (2016-2020) (Million US$) Table United States Fragment-based Drug Discovery Market Share by Type (2016-2020) Table United States Fragment-based Drug Discovery Market Size by Application (2016-2020) (Million US$) Table United States Fragment-based Drug Discovery Market Share by Application (2016-2020) Figure Europe Fragment-based Drug Discovery Market Size 2016-2020 (Million US$) Table Europe Key Players Fragment-based Drug Discovery Revenue (2020) (Million US$) Table Europe Key Players Fragment-based Drug Discovery Market Share (2020) Table Europe Fragment-based Drug Discovery Market Size by Type (2016-2020) (Million US$) Table Europe Fragment-based Drug Discovery Market Share by Type (2016-2020) Table Europe Fragment-based Drug Discovery Market Size by Application (2016-2020) (Million US$) Table Europe Fragment-based Drug Discovery Market Share by Application (2016-2020) Figure China Fragment-based Drug Discovery Market Size 2016-2020 (Million US$) Table China Key Players Fragment-based Drug Discovery Revenue (2020) (Million US$) Table China Key Players Fragment-based Drug Discovery Market Share (2020) Table China Fragment-based Drug Discovery Market Size by Type (2016-2020) (Million US$) Table China Fragment-based Drug Discovery Market Share by Type (2016-2020) Table China Fragment-based Drug Discovery Market Size by Application (2016-2020) (Million US$) Table China Fragment-based Drug Discovery Market Share by Application (2016-2020) Figure Japan Fragment-based Drug Discovery Market Size 2016-2020 (Million US$) Table Japan Key Players Fragment-based Drug Discovery Revenue (2020) (Million US$) Table Japan Key Players Fragment-based Drug Discovery Market Share (2020) Table Japan Fragment-based Drug Discovery Market Size by Type (2016-2020) (Million US$) Table Japan Fragment-based Drug Discovery Market Share by Type (2016-2020) Table Japan Fragment-based Drug Discovery Market Size by Application (2016-2020) (Million US$) Table Japan Fragment-based Drug Discovery Market Share by Application (2016-2020) Figure Southeast Asia Fragment-based Drug Discovery Market Size 2016-2020 (Million US$) Table Southeast Asia Key Players Fragment-based Drug Discovery Revenue (2020) (Million US$) Table Southeast Asia Key Players Fragment-based Drug Discovery Market Share (2020) Table Southeast Asia Fragment-based Drug Discovery Market Size by Type (2016-2020) (Million US$) Table Southeast Asia Fragment-based Drug Discovery Market Share by Type (2016-2020) Table Southeast Asia Fragment-based Drug Discovery Market Size by Application (2016-2020) (Million US$) Table Southeast Asia Fragment-based Drug Discovery Market Share by Application (2016-2020) Figure India Fragment-based Drug Discovery Market Size 2016-2020 (Million US$) Table India Key Players Fragment-based Drug Discovery Revenue (2020) (Million US$) Table India Key Players Fragment-based Drug Discovery Market Share (2020) Table India Fragment-based Drug Discovery Market Size by Type (2016-2020) (Million US$) Table India Fragment-based Drug Discovery Market Share by Type (2016-2020) Table India Fragment-based Drug Discovery Market Size by Application (2016-2020) (Million US$) Table India Fragment-based Drug Discovery Market Share by Application (2016-2020) Figure Central & South America Fragment-based Drug Discovery Market Size 2016-2020 (Million US$) Table Central & South America Key Players Fragment-based Drug Discovery Revenue (2020) (Million US$) Table Central & South America Key Players Fragment-based Drug Discovery Market Share (2020) Table Central & South America Fragment-based Drug Discovery Market Size by Type (2016-2020) (Million US$) Table Central & South America Fragment-based Drug Discovery Market Share by Type (2016-2020) Table Central & South America Fragment-based Drug Discovery Market Size by Application (2016-2020) (Million US$) Table Central & South America Fragment-based Drug Discovery Market Share by Application (2016-2020) Table Astex Pharmaceuticals Company Details Table Astex Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2020) (Million US$) Figure Astex Pharmaceuticals Revenue Growth Rate in Fragment-based Drug Discovery Business (2020) Table Astex Pharmaceuticals Recent Development Table Alveus Pharmaceuticals Company Details Table Alveus Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2020)(Million US$) Figure Alveus Pharmaceuticals Revenue Growth Rate in Fragment-based Drug Discovery Business (2020) Table Alveus Pharmaceuticals Recent Development Table Beactica Company Details Table Beactica Revenue in Fragment-based Drug Discovery Business (2020)(Million US$) Figure Beactica Revenue Growth Rate in Fragment-based Drug Discovery Business (2020) Table Beactica Recent Development Table Charles River Laboratories Company Details Table Charles River Laboratories Revenue in Fragment-based Drug Discovery Business (2020)(Million US$) Figure Charles River Laboratories Revenue Growth Rate in Fragment-based Drug Discovery Business (2020) Table Charles River Laboratories Recent Development Table Crown Bioscience Company Details Table Crown Bioscience Revenue in Fragment-based Drug Discovery Business (2020)(Million US$) Figure Crown Bioscience Revenue Growth Rate in Fragment-based Drug Discovery Business (2020) Table Crown Bioscience Recent Development Table Emerald BioStructures Company Details Table Emerald BioStructures Revenue in Fragment-based Drug Discovery Business (2020)(Million US$) Figure Emerald BioStructures Revenue Growth Rate in Fragment-based Drug Discovery Business (2020) Table Emerald BioStructures Recent Development Table Evotec Company Details Table Evotec Revenue in Fragment-based Drug Discovery Business (2020)(Million US$) Figure Evotec Revenue Growth Rate in Fragment-based Drug Discovery Business (2020) Table Evotec Recent Development Table Kinetic Discovery Company Details Table Kinetic Discovery Revenue in Fragment-based Drug Discovery Business (2020)(Million US$) Figure Kinetic Discovery Revenue Growth Rate in Fragment-based Drug Discovery Business (2020) Table Kinetic Discovery Recent Development Table Proteros Fragments Company Details Table Proteros Fragments Revenue in Fragment-based Drug Discovery Business (2020)(Million US$) Figure Proteros Fragments Revenue Growth Rate in Fragment-based Drug Discovery Business (2020) Table Proteros Fragments Recent Development Table Sprint Bioscience Company Details Table Sprint Bioscience Revenue in Fragment-based Drug Discovery Business (2020)(Million US$) Figure Sprint Bioscience Revenue Growth Rate in Fragment-based Drug Discovery Business (2020) Table Sprint Bioscience Recent Development Table Structure Based Design Company Details Table Sygnature Discovery Company Details Table Global Fragment-based Drug Discovery Market Size by Regions (Million US$) 2021-2027 Figure Global Fragment-based Drug Discovery Market Size Share by Regions (2021-2027) Figure Global Fragment-based Drug Discovery Market Size Share by Regions in 2027 Figure United States Fragment-based Drug Discovery Market Size Forecast (2021-2027)(Million USD) Figure Europe Fragment-based Drug Discovery Market Size Forecast (2021-2027)(Million USD) Figure China Fragment-based Drug Discovery Market Size Forecast (2021-2027)(Million USD) Figure Japan Fragment-based Drug Discovery Market Size Forecast (2021-2027)(Million USD) Figure Southeast Asia Fragment-based Drug Discovery Market Size Forecast (2021-2027)(Million USD) Figure India Fragment-based Drug Discovery Market Size Forecast (2021-2027)(Million USD) Figure Central & South America Fragment-based Drug Discovery Market Size Forecast (2021-2027)(Million USD) Table Global Fragment-based Drug Discovery Market Size by Product (2021-2027) (Million US$) Figure Global Fragment-based Drug Discovery Market Size by Product (2021-2027) Figure Global Fragment-based Drug Discovery Market Size by Product in 2027 Table Global Fragment-based Drug Discovery Market Size by Application (2021-2027) (Million US$) Figure Global Fragment-based Drug Discovery Market Size by Application (2021-2027) Figure Global Fragment-based Drug Discovery Market Size by Application in 2027 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Have questions about this research?

Speak directly with our analysts for custom insights

Contact Analyst
Starting From
$3900
$3900
$7800

Purchase Includes

PDF Report Comprehensive market analysis
PPT Presentation Executive summary slides
Excel Data Pack Market data & statistics
Analyst Support 10 hours of expert guidance
Free Updates 12 months data updates
Customization Up to 40 hours included

Have Any Questions?

Need a sample copy or have questions about pricing? Our team is here to help.

+1 646 583 1932